Understanding the causes and outcomes of lymphoma in Chinese patients
The Pathogenesis and Prognostic Factors of Lymphoma
Shanghai Zhongshan Hospital · NCT06203652
This study looks at the clinical and genetic details of lymphoma patients in China to see how these factors affect the disease and its outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | All |
| Sponsor | Shanghai Zhongshan Hospital (other) |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06203652 on ClinicalTrials.gov |
What this trial studies
This observational study aims to describe the clinical and genetic characteristics of lymphoma patients in China, focusing on both Hodgkin and Non-Hodgkin lymphoma. By collecting real-world data from clinical practice, the study will explore the relationship between these characteristics and the pathogenesis and prognostic factors of lymphoma. The data gathered will include patient demographics, tumor characteristics, treatment history, and outcomes, providing insights into the disease's behavior in a real-world setting.
Who should consider this trial
Good fit: Ideal candidates include patients with a confirmed diagnosis of lymphoma who have complete medical records from 2007 to 2027.
Not a fit: Patients with severe mental illness or those who refuse to comply with contraception requirements may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of lymphoma, leading to improved prognostic assessments and treatment strategies for patients.
How similar studies have performed: Other studies have shown success in understanding lymphoma through observational approaches, indicating that this methodology is both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with pathological diagnosis of lymphoma (including Hodgkin lymphoma and non-Hodgkin lyphoma, eg. THRLBCL, DLBCL, MZL, CLL/SLL...) from 2007 to 2027. * Patients with complete diagnostic, treatment and follow-up records. * Fully comprehension and signature of the informed consent form (ICF) for participation. Exclusion Criteria: * Those who refuse to use reliable methods of contraception during pregnancy, lactation or age-appropriate period. * Severe mental illness. * Patients deemed unsuitable for inclusion by the investigator.
Where this trial is running
Shanghai, Shanghai Municipality
- Zhongshan Hospital，Fudan University — Shanghai, Shanghai Municipality, China (RECRUITING)
Study contacts
- Study coordinator: Peng Liu, Ph.D
- Email: liu.peng@zs-hospital.sh.cn
- Phone: +862164041990
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lymphoma, Hodgkin Lymphoma, Non-hodgkin Lymphoma, lymphoma, Hodgkin lymphoma, Non-Hodgkin lymphoma, THRLBCL, DLBCL